Agenus Financials
| AJ81 Stock | EUR 7.80 0.00 0.00% |
Agenus |
Understanding current and past Agenus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Agenus' financial statements are interrelated, with each one affecting the others. For example, an increase in Agenus' assets may result in an increase in income on the income statement.
The data published in Agenus' official financial statements usually reflect Agenus' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Agenus Inc. For example, before you start analyzing numbers published by Agenus accountants, it's critical to develop an understanding of what Agenus' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Agenus' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Agenus' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Agenus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Agenus Inc. Please utilize our Beneish M Score to check the likelihood of Agenus' management manipulating its earnings.
Agenus Stock Summary
Agenus competes with Novo Nordisk, and BioNTech. Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the bodys immune system to fight cancer. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. AGENUS INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 294 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US00847G7051 |
| Business Address | 3 Forbes Road, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | NYSE Composite |
| Website | www.agenusbio.com |
| Phone | 781 674 4400 |
| Currency | EUR - Euro |
You should never invest in Agenus without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Agenus Stock, because this is throwing your money away. Analyzing the key information contained in Agenus' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Agenus Key Financial Ratios
Generally speaking, Agenus' financial ratios allow both analysts and investors to convert raw data from Agenus' financial statements into concise, actionable information that can be used to evaluate the performance of Agenus over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Agenus Inc reports annually and quarterly.Agenus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Agenus's current stock value. Our valuation model uses many indicators to compare Agenus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Agenus competition to find correlations between indicators driving Agenus's intrinsic value. More Info.Agenus Inc is rated third in return on equity category among related companies. It is rated third in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Agenus by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Agenus' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Agenus' earnings, one of the primary drivers of an investment's value.Agenus Inc Systematic Risk
Agenus' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Agenus volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Agenus Inc correlated with the market. If Beta is less than 0 Agenus generally moves in the opposite direction as compared to the market. If Agenus Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Agenus Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Agenus is generally in the same direction as the market. If Beta > 1 Agenus moves generally in the same direction as, but more than the movement of the benchmark.
About Agenus Financials
What exactly are Agenus Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Agenus' income statement, its balance sheet, and the statement of cash flows. Potential Agenus investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Agenus investors may use each financial statement separately, they are all related. The changes in Agenus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Agenus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Agenus Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Agenus is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Agenus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Agenus' financials are consistent with your investment objective using the following steps:- Review Agenus' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Agenus' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Agenus' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Agenus' stock is overvalued or undervalued.
Agenus April 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Agenus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Agenus Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Agenus Inc based on widely used predictive technical indicators. In general, we focus on analyzing Agenus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Agenus's daily price indicators and compare them against related drivers.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 50.01 | |||
| Value At Risk | (9.76) | |||
| Potential Upside | 9.54 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Agenus Stock analysis
When running Agenus' price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |